Middle East and Africa Infusion Pumps Market is segmented By Product Type (Implantable Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Volumetric Infusion Pumps, Others), By Application (Diabetes, Chemotherapy/Oncology, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others), By End-User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, Academic & Research Institutes, Others) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Report Overview
Middle East and Africa Infusion Pumps Market reached US$ 38.2 million in 2023 and is expected to reach US$ 47.9 million by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031.
Infusion pumps are often used in hospitals and other human care organizations to administer medications and fluids to patients' bodies in a regulated way. These infusion pumps enhance the treatment of patients receiving opioids, pain relievers, antibiotics, and other medications. Infusion sets help give medications and fluids such as saline, dextrose, and plasma solutions.
Infusion pumps allow for highly viscous medications to be administered through small catheters into the veins. Medication is usually administered this way through the dorsal veins of the hand, the forearm, the arm, the dorsal veins of the foot, the inguinal region and the antecubital fossa.
Market Scope
|
Metrics |
Details |
|
CAGR |
5.2% |
|
Market Size Available for Years |
2022-2031 |
|
Estimation Forecast Period |
2024-2031 |
|
Revenue Units |
Value (US$ Mn) |
|
Segments Covered |
Product Type, Application, End-User |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Growing prevalence of chronic diseases
The rise of chronic conditions such as diabetes, cancer, and cardiovascular disease is a major factor driving demand for infusion pumps. Chronic patients require long-term medical therapy, thus precise and safe drug delivery methods are crucial. Infusion pumps provide the regulated administration of drugs, reducing adverse effects and improving treatment outcomes.
For instance, according to a report by the National Institute of Health in 2022, it is stated that in Africa, CVDs are the largest contributor to the total non-communicable diseases (NCDs) burden, accounting for 38.3% of NCD deaths and 22.9 million DALYs.
Additionally, according to the report by the International Diabetes Federation in 2022, it is stated that in the Middle East and North Africa, 1 in 6 adults (73 million) are living with diabetes and the number of adults with diabetes is predicted to rise to 136 million by 2045, an increase of 87%. Thus, the above factors could increase the demand for infusion pumps which is expected to drive the market growth.
Regulatory hurdles
Regulatory limitations involved with approving infusion pumps are projected to hinder industry growth. Ensuring that infusion pumps meet tight regulatory requirements pays significant costs. These can include costs for clinical investigations, paperwork, quality control procedures, and GMP compliance. Startups and smaller companies could find these expenses too costly.
Market Segment Analysis
The Middle East and Africa infusion pumps market is segmented based on product type, application, and end-user.
Insulin infusion pumps segment is expected to dominate the market share
Insulin infusion pumps segment is expected to hold a significant position in the market share. Insulin is continuously administered by insulin infusion pumps, which provide an integrated strategy for managing diabetes. This delicate control over insulin delivery enhances the overall management of diabetes and assists in maintaining ideal blood glucose levels.
Compared to conventional insulin injection techniques, insulin pumps offer several advantages, including improved glucose management, fewer injections, and increased flexibility in day-to-day activities. Consumer choice is influenced by this enhanced quality of life, which also fuels the segment's expansion.
Market Segmentation
By Product Type
- Implantable Infusion Pumps
- Insulin Infusion Pumps
- Syringe Infusion Pumps
- Volumetric Infusion Pumps
- Others
By Application
- Diabetes
- Chemotherapy/Oncology
- Gastroenterology
- Analgesia/Pain Management
- Pediatrics/Neonatology
- Hematology
- Others
By End-User
- Hospitals & Clinics
- Ambulatory Care Settings
- Home Care Settings
- Academic & Research Institutes
- Others
Market Competitive Landscape
The major players in the market include B. Braun SE, Becton, Dickinson and Company, Insulet Corporation, Fresenius Kabi South Africa (Pty) Ltd, Terumo, Contec Medical Systems Co., Ltd, Nipro South Africa, ICU Medical Inc. and Allied Medical Ltd. among others.
Why Purchase the Report?
- To visualize the Middle East and Africa Infusion Pumps market segmentation based on product type, application, and end-user as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of infusion pumps market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The Middle East and Africa infusion pumps market report would provide approximately 53 tables, 47 figures, and 176 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
